Hematology/Oncology

Top Story

Roswell Park Cancer Institute names department chairman

April 23, 2017

John Krolewski , MD, PhD, has been named chair of the department of cancer genetics and genomics at Roswell Park Cancer Institute.

Krolewski — who served as interim chair of the department since March 2016 — also will serve as co-leader of the cancer center support grant genetics and genomics program, and he will hold the John and Santa Palisano endowed chair of cancer genetics and genomics.

Terms of Abbott acquisition of Alere changed, lawsuits dropped

April 23, 2017
Abbott and Alere announced that the terms for Abbott’s pending acquisition of Alere have been amended and the companies have ceased litigation against each other…

Association of Community Cancer Centers names 2017-2018 president

April 22, 2017
Mark S. Soberman , MD, MBA, FACS, has been elected president of the Association of Community Cancer Centers for the 2017-2018 term. Soberman —…
Meeting News

Sorafenib, selective internal radiation yield similar survival in HCC

April 22, 2017
AMSTERDAM — Selective internal radiation therapy failed to best Nexavar in overall survival but did yield improvements in other parameters, including quality of…
In the Journals Plus

Women considering double mastectomies satisfied with surgery choices

April 21, 2017
More News Headlines »
CME

Breakthroughs in the Treatment of Bladder Cancer

This activity is supported by an educational grant from Bristol-Myers Squibb.

Assessment of immune checkpoint blockade inhibitors in the treatment of bladder cancer have demonstrated significant…
More »
Video
Meeting News

VIDEO: Speaker compares single-agent vs. combination immunotherapy for melanoma

April 9, 2017
More »
Featured
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting

CME

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement